Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Padraig Warde

Showing results (151-160 of 174) with videos related to

Pageof 18
Sort By:
BJU International|May 5, 2018
Gene expression signatures prognostic for relapse in stage I testicular germ cell tumoursJeremy Lewin, Laleh Soltan Ghoraie, Philippe L Bedard, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 11, 2016
Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods studyMartine T E Puts, Schroder Sattar, Kara McWatters, et al.
Journal of Geriatric Oncology|March 29, 2023
Symptom experiences of older adults during treatment for metastatic prostate cancer: A qualitative investigationMilothy Parthipan, Gregory Feng, Nelly Toledano, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 16, 2016
The initiation of a multidisciplinary bladder cancer clinic and the uptake of neoadjuvant chemotherapy: A time-series analysisMadhur Nayan, Bimal Bhindi, Julie L Yu, et al.
Lancet (London, England)|November 8, 2011
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trialPadraig Warde, Malcolm Mason, Keyue Ding, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2020
Clinical dilemmas in local and regional testis cancerGregory J Nason, Ricardo A Rendon, Lori Wood, et al.
The Journal of Urology|February 24, 2018
Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell TumorRicardo Leão, Ton van Agthoven, Arnaldo Figueiredo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 24, 2026
Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomesJohn Mohan Mathew, Hannah Bacon, Jeff Winter, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell TumorsJeremy Lewin, Paul Dufort, Jaydeep Halankar, et al.
BMJ Open|April 25, 2020
[<sup>18</sup>F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trialRachel M Glicksman, Ur Metser, John Valliant, et al.
Pageof 18

Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
BJU International|May 5, 2018
Gene expression signatures prognostic for relapse in stage I testicular germ cell tumoursJeremy Lewin, Laleh Soltan Ghoraie, Philippe L Bedard, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 11, 2016
Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods studyMartine T E Puts, Schroder Sattar, Kara McWatters, et al.
Journal of Geriatric Oncology|March 29, 2023
Symptom experiences of older adults during treatment for metastatic prostate cancer: A qualitative investigationMilothy Parthipan, Gregory Feng, Nelly Toledano, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 16, 2016
The initiation of a multidisciplinary bladder cancer clinic and the uptake of neoadjuvant chemotherapy: A time-series analysisMadhur Nayan, Bimal Bhindi, Julie L Yu, et al.
Lancet (London, England)|November 8, 2011
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trialPadraig Warde, Malcolm Mason, Keyue Ding, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2020
Clinical dilemmas in local and regional testis cancerGregory J Nason, Ricardo A Rendon, Lori Wood, et al.
The Journal of Urology|February 24, 2018
Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell TumorRicardo Leão, Ton van Agthoven, Arnaldo Figueiredo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 24, 2026
Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomesJohn Mohan Mathew, Hannah Bacon, Jeff Winter, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell TumorsJeremy Lewin, Paul Dufort, Jaydeep Halankar, et al.
BMJ Open|April 25, 2020
[<sup>18</sup>F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trialRachel M Glicksman, Ur Metser, John Valliant, et al.
Pageof 18